Библиотека >> Статьи

Роль воспаления в развитии рака простаты или есть ли связь между простатитом и раком простаты

По материалам Journal Urology (Vol. 172, S6-S12, Ноябрь 2004) Американская урологическая ассоциация WILLIAM G. NELSON, ANGELO M. DE MARZO, THEODORE L. DeWEESE и WILLIAM B. ISAACS
Перевод: к.м.н. Сорокин К. В.

• Краткое содержание (абстракт)
• Введение
• Эпидемиология
• Генетические аспекты развития рака простаты (информация для специалистов)
• Молекулярные аспекты развития рака простаты (информация для профессионалов)
• Заключение
• Обсуждение статьи специалистами
• Литература

Список литературы

1. Hsing, A. W., Tsao, L. and Devesa, S. S.: International trends and patterns of prostate cancer incidence and mortality. Int J Cancer, 85: 60, 2000
2. Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R. et al: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst, 87: 652, 1995
3. Gann, P. H., Hennekens, С H., Sacks, F. M., Grodstein, F., Giovannucci, E. L. and Stampfer, M. J.: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst, 86: 281, 1994
4. Cohen, J. H., Kristal, A. R. and Stanford, J. L.: Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst, 92: 61, 2000
5. Le Marchand, L., Kolonel, L. N., Wilkens, L. R., Myers, В. С and Hirohata, T.: Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology, 5: 276, 1994
6. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C. et al: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst, 85: 1571, 1993
7. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J. et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276: 1957, 1996
8. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H. et al: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81: 730, 1998
9. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M. et al: Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90: 440, 1998
10. Shirai, T., Sano, M., Tamano, S., Takahashi, S., Hirose, M., Futakuchi, M. et al: The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res, 57: 195, 1997
11. Stuart, G. R., Holcroft, J., de Boer, J. G. and Glickman, B. W.: Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res, 60: 266, 2000
12. Gardner, W. A., Jr. and Bennett, B. D.: The prostate overview: recent insights and speculations. In: Pathology and Pathobi-ology of the Urinary Bladder and Prostate. Edited by R. S. Weinstein and W. A. Gardner, Jr. Baltimore: Williams & Wilkens Co., pp. 129-148, 1992
13. Nelson, W. G., De Marzo, A. M. and Isaacs, W. B.: Prostate cancer. N Engl J Med, 349: 366, 2003
14. Coleman, W. B.: Mechanisms of human hepatocarcinogenesis. Curr Mol Med, 3: 573, 2003
15. Roberts, R. O., Lieber, M. M., Rhodes, T., Girman, С J., Bostwick, D. G. and Jacobsen, S. J.: Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology, 51: 578, 1998
16. Hoekx, L., Jeuris, W., Van Marck, E. and Wyndaele, J. J.: Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation. Acta Urol Belg, 66: 1, 1998
17. Carver, B. S., Bozeman, C. B., Williams, B. J. and Venable, D. D.: The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol, 169: 589, 2003
18. Krieger, J. N., Riley, D. E., Cheah, P. Y., Liong, M. L. and Yuen, K. H.: Epidemiology of prostatitis: new evidence for a worldwide problem. World J Urol, 21: 70, 2003
19. Dennis, L. K. and Dawson, D. V.: Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology, 13: 72, 2002
20. Dennis, L. K., Lynch, С F. and Torner, J. C.: Epidemiologic association between prostatitis and prostate cancer. Urology, 60: 78, 2002 21. Hayes, R. B., Pottern, L. M., Strickler, H., Rabkin, C., Pope, V.,Swanson, G. M. et al: Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer, 82: 718, 2000
22. Habel, L. A., Zhao, W. and Stanford, J. L.: Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control, 13: 427, 2002
23. Leitzmann, M. F., Stampfer, M. J., Ma, J., Chan, J. M., Colditz, G. A., Willett, W. С et al: Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 11: 1108, 2002
24. Perron, L., Bairati, I., Moore, L. and Meyer, F.: Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer, 106: 409, 2003
25. Roberts, R. O., Jacobson, D. J., Girman, С J., Rhodes, T., Lieber, M. M. and Jacobsen, S. J.: A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc, 77: 219, 2002
26. Irani, J., Ravery, V., Pariente, J. L., Chartier-Kastler, E., Lechevallier, E., Soulie, M. et al: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol, 168: 1985, 2002
27. Langman, M. J., Cheng, K. K., Gilman, E. A. and Lancashire, R. J.: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ, 320: 1642, 2000
28. Zha, S., Gage, W. R., Sauvageot, J., Saria, E. A., Putzi, M. J., Ewing, С M. et al: Cyclooxygenase-2 is up-regulated in pro-liferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res, 61: 8617, 2001
29. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B. et al: Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90: 1219, 1998
30. Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., Nelson, W. G. et al: Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol, 166: 2034, 2001
31. Vogt, T. M., Ziegler, R. G., Graubard, B. I., Swanson, C. A., Greenberg, R. S., Schoenberg, J. B. et al: Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer, 103: 664, 2003
32. van den Brandt, P. A., Zeegers, M. P., Bode, P. and Goldbohm, R. A.: Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev, 12: 866, 2003
33. Duffield-Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W., Slate, E. H., Jacobs, E. T. et al: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int, 91: 608, 2003
34. Helzlsouer, K. J., Huang, H. Y., Alberg, A. J., Hoffman, S., Burke, A., Norkus, E. P. et al: Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst, 92: 2018, 2000
35. Huang, H. Y., Alberg, A. J., Norkus, E. P., Hoffman, S. C., Comstock, G. W. and Helzlsouer, K. J.: Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol, 157: 335, 2003
36. Chan, J. M., Stampfer, M. J., Ma, J., Rimm, E. B., Willett, W. С and Gioannucci, E. L.: Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev, 8: 893, 1999
37. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med, 330: 1029, 1994
38. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colitz, G. A. and Willett, W. C.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst, 87: 1767, 1995
39. Gann, P. H., Ma, J., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H. et al: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res, 59: 1225, 1999
40. Chen, L., Stacewicz-Sapuntzakis, M., Duncan, C., Sharifi, R., Ghosh, L., van Breemen, R. et al: Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst, 93: 1872, 2001
41. Dinkova-Kostova, A. T. and Talalay, P.: Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic Biol Med, 29: 231, 2000
42. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y. et al: Direct evidence that sulfhy-dryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxi-dants. Proc Natl Acad Sci USA, 99: 11908, 2002
43. Morganti, G., Gianferrari, L., Cresseri, A., Arrigoni, G. and Lovati, G.: Clinico-statistical and genetic research on neoplasms of the prostate. Acta Genet Stat Med, 6: 304, 1956-1957
44. Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B. and Walsh, P. C.: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA, 89: 3367, 1992
45. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvu, M. et al: Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343: 78, 2000
46. Smith, J. R., Freije, D., Carpten, J. D., Gronberg, H., Xu, J., Isaacs, S. D. et al: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science, 274: 1371, 1996
47. Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J. et al: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet, 30:181, 2002
48. Floyd-Smith, G., Slattery, E. and Lengyel, P.: Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate-dependent endonuclease. Science, 212: 1030, 1981
49. Zhou, A., Hassel, B. A. and Silverman, R. H.: Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell, 72: 753, 1993
50. Casey, G., Neville, P. J., Plummer, S. J., Xiang, Y., Krumroy, L. M., Klein, E. A. et al: RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet, 32: 581, 2002
51. Xiang, Y., Wang, Z., Murakami, J., Plummer, S., Klein, E. A., Carpten, J. D. et al: Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Cancer Res, 63: 6795, 2003
52. Zhou, A., Paranjape, J., Brown, T. L., Nie, H., Dong, B., Chang, A. et al: Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J, 16: 6355, 1997
53. Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J. et al: Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32: 321, 2002
54. Platt, N. and Gordon, S.: Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale. J Clin Invest, 108: 649, 2001
55. Miller, D. C., Zheng, S. L., Dunn, R. L., Sarma, A. V., Montie, J. E., Lange, E. M. et al: Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Res, 63: 3486, 2003
56. Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Chang, B. et al: Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am J Hum Genet, 72: 208, 2003
57. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K. et al: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature, 386: 292, 1997
58. Thomas, С A., Li, Y., Kodama, T., Suzuki, H., Silverstein, S. С and El Khoury, J.: Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med, 191: 147, 2000
59. Woodson, K., Tangrea, J. A., Lehman, T. A., Modali, R., Taylor, K. M., Snyder, К et al: Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control, 14: 513, 2003
60. Xu, J., Zheng, S. L., Turner, A., Isaacs, S. D., Wiley, K. E., Hawkins, G. A. et al: Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res, 62: 2253, 2002
61. Chen, L., Elahi, A., Pow-Sang, J., Lazarus, P. and Park, J.: Association between polymorphism of human oxoguanine gly-cosylase 1 and risk of prostate cancer. J Urol, 170: 2471, 2003
62. McCarron, S. L., Edwards, S., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A. et al: Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res, 62: 3369, 2002
63. Lin, X., Tascilar, M., Lee, W. H., Vles, W. J., Lee, B. H., Veeraswamy, R. et al: GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol, 159: 1815, 2001
64. De Marzo, A. M., Marchi, V. L., Epstein, J. I. and Nelson, W. G.: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol, 155: 1985, 1999
65. Nelson, С P., Kidd, L. C., Sauvageot, J., Isaacs, W. B., De Marzo, A. M., Groopman, J. D. et al: Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cy-totoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res, 61: 103, 2001
66. Henderson, С J., Smith, A. G., Ure, J., Brown, K., Bacon, E. J. and Wolf, C. R.: Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA, 95: 5275, 1998
67. Parsons, J. K., Nelson, С P., Gage, W. R., Nelson, W. G., Kensler, T. W. and De Marzo, A. M.: GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. Prostate, 49: 30, 2001
68. van Leenders, G. J., Gage, W. R., Hicks, J. L., van Balken, B., Aalders, T. W., Schalken, J. A. et al: Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol, 162: 1529, 2003
69. Putzi, M. J. and De Marzo, A. M.: Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology, 56: 828, 2000
70. Takayama, H., Shin, M., Nonomura, N., Okuyama, A. and Aozasa, K.: p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture micro-dissected specimens from non-transition and transition zones. Jpn J Cancer Res, 91: 941, 2000
71. Tsujimoto, Y., Takayama, H., Nonomura, N., Okuyama, A. and Aozasa, K.: Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis. Prostate, 52: 279, 2002
72. Shah, R., Mucci, N. R., Amin, A., Macoska, J. A. and Rubin, M. A.: Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol, 158: 1767, 2001
73. Nakayama, M., Bennett, С J., Hicks, J. L., Epstein, J. I., Platz, E. A., Nelson, W. G. et al: Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol, 163: 923, 2003
74. Correa, P.: Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 52: 6735, 1992
75. Wong, B. C., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E. et al: Helicobacter pylori eradication to prevent gastric cancer in a high risk region of China: a randomized controlled trial. JAMA, 291: 187, 2004
76. Ohkawa, M., Yamaguchi, K., Tokunaga, S., Nakashima, T. and Fujita, S.: Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology. Br J Urol, 72: 918, 1993
77. Ulleryd, P., Zackrisson, B., Aus, G., Bergdahl, S., Hugosson, J. and Sandberg, T.: Prostatic involvement in men with febrile urinary tract infections measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int, 84: 470, 1999
78. Oliver, J. C., Oliver, R. T. and Ballard, R. C.: Influence of circumcision and sexual behavior in patients attending a sexually transmitted disease (STD) clinic. Prostate Cancer Prostatic Dis, 4: 228, 2001
79. Zackrisson, B., Ulleryd, P., Aus, G., Lilja, H., Sandberg, T. and Hugosson, J.: Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with urinary tract infection. Urology, 62: 278, 2003
80. Reyes, N., Iatropoulos, M., Mittelman, A. and Geliebter, J.: Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostate. Eur J Cancer Prev, suppl., 11: S37, 2002

Обсудить статью на форуме

Перевод:

   Сорокин Константин Владимирович